This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meléndez, M.
Right arrow Articles by Rodríguez, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meléndez, M.
Right arrow Articles by Rodríguez, J. F.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, March 2006, p. 835-840, Vol. 50, No. 3
0066-4804/06/$08.00+0     doi:10.1128/AAC.50.3.835-840.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Lack of Evidence for In Vivo Transformation of Zidovudine Triphosphate to Stavudine Triphosphate in Human Immunodeficiency Virus-Infected Patients

Margarita Meléndez,1 Raúl Blanco,2 Wilfredo Delgado,2 Rosario García,2 Jorge Santana,3 Hermes García,4 Osvaldo Rosario,1 and José F. Rodríguez2,3*

Department of Chemistry, Río Piedras Campus, University of Puerto Rico,1 Department of Biochemistry, School of Medicine, Medical Sciences Campus, University of Puerto Rico,2 AACTU-Department of Medicine, School of Medicine, Medical Sciences Campus, University of Puerto Rico,3 Puerto Rico Health Department (CLETS), San Juan, Puerto Rico4

Received 24 August 2005/ Returned for modification 29 October 2005/ Accepted 8 December 2005

The in vivo and in vitro determination of significant intracellular stavudine (d4T) triphosphate (d4TTP) concentrations in human immunodeficiency virus (HIV)-infected subjects and NS-1 cells treated with zidovudine (ZDV) has recently been reported. This study was conducted to corroborate these findings with in vivo samples from HIV-infected subjects taking ZDV and in vitro CEMSS cells incubated with different ZDV concentrations. Previously, we have reported on our validated high-performance liquid chromatography coupled with tandem mass spectrometry methodology for the simultaneous determination of d4TTP, lamivudine triphosphate, and ZDV triphosphate (ZDVTP) concentrations. Using this methodology, we monitored the d4TTP concentration in more than 100 samples from HIV-infected subjects treated with d4T. In addition, we simultaneously monitored the concentrations of d4TTP and ZDVTP in more than 500 samples from HIV-infected individuals who were taking ZDV. Finally, we performed in vitro studies by incubating CEMSS cells with 10 µM, 50 µM, and 100 µM ZDV and monitored the formation of d4TTP at 24 and 48 h. We could measure d4TTP concentrations from HIV-infected individuals with a limit of quantitation (LOQ) of 2.7 fmol/106 cells (total injection, 54 fmol). In the in vivo studies, we measured the d4TTP concentrations among patients receiving d4T treatment, but the samples from patients taking ZDV did not provide d4TTP concentrations above the LOQ. Furthermore, in vitro samples did not produce any signal for d4TTP, despite the detection of substantial ZDVTP concentrations in CEMSS cells. Thus, contrary to the previous report, we found no evidence for the in vivo or in vitro transformation of ZDVTP to d4TTP in HIV-infected subjects or CEMSS cells.

* Corresponding author. Mailing address: Department of Biochemistry, P.O. Box 365067, School of Medicine, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico 00936-5067. Phone and fax: (787) 754-4929. E-mail: jrodriguez{at}rcm.upr.edu.

Antimicrobial Agents and Chemotherapy, March 2006, p. 835-840, Vol. 50, No. 3
0066-4804/06/$08.00+0     doi:10.1128/AAC.50.3.835-840.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Susan-Resiga, D., Bentley, A. T., Lynx, M. D., LaClair, D. D., McKee, E. E. (2007). Zidovudine Inhibits Thymidine Phosphorylation in the Isolated Perfused Rat Heart. Antimicrob. Agents Chemother. 51: 1142-1149 [Abstract] [Full Text]  
  • Benech, H., Becher, F., Pruvost, A., Grassi, J. J., Melendez, M., Rodriguez, J. F. (2006). Is Stavudine triphosphate a natural metabolite of Zidovudine?. Antimicrob. Agents Chemother. 50: 2899-2901 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»